Use Case

How large medical groups use payor rate benchmarking to negotiate better contracts

Benchmarking isn't a research exercise. It's the foundation of every contract negotiation that moves rates in the right direction.

A payor contract renegotiation is one of the highest-leverage financial events in a medical group's calendar. The rates locked into that contract will govern every claim you submit for the next three to five years. Yet most practices begin the process with no external benchmark, no market data, and no way to know whether the rates they're being offered are reasonable — or 30% below what the practice across town is already getting.

Payor rate benchmarking is the process of establishing that market context — systematically, by code, by payor, by geography. This page explains what that process looks like for large medical groups, what the data reveals, and how leading practices are using it to drive meaningful contract improvements.

What benchmarking actually means

The term "benchmarking" is used loosely in healthcare. For the purposes of payor contract strategy, it means one specific thing: knowing the rates that comparable providers — same specialty, overlapping market, similar patient volume — are currently receiving from the same payors for the same procedure codes.

This is distinct from:

  • Medicare fee schedules, which set a reference point but don't reflect commercial market dynamics
  • Usual and customary rates, which are a statistical construct, not a market rate
  • Your own historical rates, which tell you where you've been, not where the market is
  • What a billing consultant estimates, based on experience rather than current disclosed data

True benchmarking is grounded in the actual negotiated rates that exist in the market today — and since the Transparency in Coverage rule took effect, that data is available for the first time.

How large groups approach the process

They start with revenue concentration

In most specialty practices, 20 to 30 CPT codes represent 70 to 80 percent of annual revenue. Benchmarking efforts that start here — rather than attempting to analyze every code on the fee schedule — produce faster, more actionable insights.

They look at the right peer set

Benchmarking against the wrong peer group produces misleading conclusions. A large multi-state PT group should not benchmark against a solo practitioner in a rural market. The relevant peer set consists of practices of comparable size, in comparable markets, with comparable payor mix.

They account for rate modifiers

Gross per-code rates are not always the right unit of comparison. Practices that bill multiple procedures per visit need to look at effective per-visit rates after MPPR reductions. The goal is an apples-to-apples comparison that reflects how the practice actually collects revenue.

They track results across negotiation cycles

Benchmarking is not a one-time exercise. Payor rates shift, new competitors enter markets, and practices that were at the 75th percentile two years ago may find themselves at the median today. Ongoing monitoring allows large groups to identify which contracts are drifting below market before the gap becomes substantial.

40%

Typical spread between highest and lowest rates in a market for the same CPT code

3–5 yr

Length of most payor contracts — the cost of a bad rate compounds across every year

12–18mo

Lead time needed to prepare a data-informed renegotiation before contract expiry

Beyond contract renegotiation

Once a large group has invested in building out a rate benchmarking capability, the applications extend well beyond the negotiating table. The same data that tells you what your competitors are being paid also tells you:

  • Which markets offer above-average reimbursement — useful for expansion planning
  • Which practices in your market have below-average rates — potential acquisition or recruitment targets
  • What a target acquisition practice is likely realizing versus what the market would support post-integration
  • Whether an in-network contract is worth accepting, and at what floor rate

Leading PE-backed groups and large independent practices increasingly treat rate intelligence as a strategic asset — something that informs not just contracts, but growth decisions.

HOW PAYOROLOGY APPROACHES THIS
We curate and vet the benchmarking data specifically for the specialty our client is in, building in the nuances that matter — MPPR treatment, facility vs. non-facility rates, geographic adjustments. Every client's portal is built around the codes and payors that drive their revenue, not a generic fee schedule. And our team is available to work through what the data means, not just deliver a spreadsheet. 

Mitch Spolan

Mitch Spolan

Co-Founder and CEO

Mitch is the CEO and Co-Founder of Payorology. He co-founded the company on a simple belief: medical groups should be fairly reimbursed for the care they provide patients.

Find out where your rates stand

We'll show you exactly where you sit relative to your peers before your next renewal.

Payorology Logo